Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks.
Marc A RiedlMarcus MaurerJonathan A BernsteinAleena BanerjiHilary J LonghurstH Henry LiPeng LuJames HaoSalomé JuethnerWilliam R Lumrynull nullPublished in: Allergy (2020)
Protection with lanadelumab started from the first dose and continued throughout the entire study period.